RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 20:02:20 GMT 2025` Edited by `admin` on `Tue Apr 01 20:02:20 GMT 2025`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	L6AQO0405O
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CELL DEATH PROTEIN RIP

Preferred Name

English

RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1

Common Name

English

RIP1

Common Name

English

RIP

Common Name

English

RECEPTOR-INTERACTING PROTEIN 1

Common Name

English

SERINE/THREONINE-PROTEIN KINASE RIP

Common Name

English

RIPK1

Common Name

English

RIP-1

Common Name

English

Code System Code Type Description

PHAROS

Q13546

Created by admin on Tue Apr 01 20:02:20 GMT 2025 , Edited by admin on Tue Apr 01 20:02:20 GMT 2025

PRIMARY

FDA UNII

L6AQO0405O

Created by admin on Tue Apr 01 20:02:20 GMT 2025 , Edited by admin on Tue Apr 01 20:02:20 GMT 2025

PRIMARY

UNIPROT

Q13546

Created by admin on Tue Apr 01 20:02:20 GMT 2025 , Edited by admin on Tue Apr 01 20:02:20 GMT 2025

PRIMARY

Related Record Type Details


					8QQK385682

N-[(3,5-Difluorophenyl)methyl]-N-hydroxy-2,2-dimethylbutanamide

INHIBITOR -> TARGET

Interaction Type:

ALLOSTERIC

Qualification:

IC50

Amount:


					I1YQT8HC89

Oditrasertib

INHIBITOR -> TARGET

Amount:


					S53J4A7ME4

Ocadusertib

INHIBITOR -> TARGET

Interaction Type:

PRECLINICAL

Amount:


					975AT1P9J6

ECLITASERTIB

INHIBITOR -> TARGET

Amount:


					6GA6XSX5SL

Fosizensertib

INHIBITOR -> TARGET

Interaction Type:

PRECLINICAL

Amount:


					B4D3WPS7JY

GSK-3145095

INHIBITOR -> TARGET

Qualification:

IC50

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_6] [1_25] [1_303] [1_320] [1_333]				DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL